Starling Oncology (STLN) EBITDA Margin Growth (1y) (2022 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) EBITDA Margin Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | -519.00 |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | 1,106.00 |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | -101.00 |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 38.00 |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | -54.00 |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 4.00 |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | 215.00 |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | 151.00 |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 273.00 |
| 10 | Starling Oncology | 609.95 Mn | 568.85 Mn | 27.17 Mn | 633.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 633.00 |
| Mar 31, 2026 | 472.00 |
| Dec 31, 2025 | 675.00 |
| Sep 30, 2025 | 790.00 |
| Jun 30, 2025 | 735.00 |
| Mar 31, 2025 | 970.00 |
| Dec 31, 2024 | 591.00 |
| Sep 30, 2024 | 279.00 |
| Jun 30, 2024 | 203.00 |
| Mar 31, 2024 | 2,420.00 |
| Dec 31, 2023 | 1,759.00 |
| Sep 30, 2023 | 1,446.00 |
| Jun 30, 2023 | 1,158.00 |
| Mar 31, 2023 | -951.00 |
| Dec 31, 2022 | 4,310.00 |
| Sep 30, 2022 | -2,663.00 |
| Jun 30, 2022 | -2,756.00 |
| Mar 31, 2022 | -2,965.00 |